Adenoviral gene therapy in head and neck cancer.

Abstract excerpt

Despite advances in surgical techniques, improvement in radiation therapy and the addition of new biological agents such as cetuximab to traditional chemotherapy, the median survival of patients with head and neck cancer has changed little over the past few decades. However, recent advances in the fundamental understanding of head and neck cancer biology suggest that targeting molecular pathways underlying...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adenoviridae
• Share to Clinical Trials as Topic
• Share to Combined Modality Therapy